Valuation Agilent Technologies, Inc.
Equities
A
US00846U1016
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.81 USD | +0.74% |
|
-2.91% | -7.54% |
| 02-11 | Agilent Technologies Inc. Announces Cash Dividend, Payable on April 22, 2026 | CI |
| 02-11 | Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award | RE |
Company Valuation: Agilent Technologies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: October | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 47,676 | 40,957 | 30,245 | 37,442 | 41,493 | 35,584 | - | - |
| Change | - | -14.09% | -26.16% | 23.8% | 10.82% | -14.24% | - | - |
| Enterprise Value (EV) 1 | 48,830 | 42,673 | 31,390 | 39,503 | 43,058 | 36,434 | 35,094 | 33,923 |
| Change | - | -12.61% | -26.44% | 25.85% | 9% | -15.38% | -3.68% | -3.34% |
| P/E ratio | 40x | 33.1x | 24.7x | 29.4x | 32x | 23.6x | 21.3x | 18.5x |
| PBR | 8.83x | 7.8x | 5.23x | 6.43x | 6.17x | 4.56x | 3.84x | 3.3x |
| PEG | - | 5.43x | 103.25x | 5.13x | 10.13x | 1.4x | 2x | 1.2x |
| Capitalization / Revenue | 7.54x | 5.98x | 4.43x | 5.75x | 5.97x | 4.84x | 4.55x | 4.27x |
| EV / Revenue | 7.73x | 6.23x | 4.59x | 6.07x | 6.2x | 4.95x | 4.49x | 4.07x |
| EV / EBITDA | 29.6x | 20.8x | 16.1x | 21.1x | 21.9x | 17.3x | 15.1x | 13.2x |
| EV / EBIT | 32.1x | 23x | 16.7x | 23x | 24.1x | 18.8x | 16.6x | 14.6x |
| EV / FCF | 37.6x | 41.8x | 21.3x | 28.8x | 37.4x | 30.5x | 22.5x | - |
| FCF Yield | 2.66% | 2.39% | 4.7% | 3.48% | 2.68% | 3.28% | 4.45% | - |
| Dividend per Share 2 | 0.776 | 0.84 | 0.9 | 0.944 | 0.992 | 1.03 | 1.087 | 1.013 |
| Rate of return | 0.49% | 0.61% | 0.87% | 0.72% | 0.68% | 0.82% | 0.86% | 0.81% |
| EPS 2 | 3.94 | 4.18 | 4.19 | 4.43 | 4.57 | 5.333 | 5.9 | 6.796 |
| Distribution rate | 19.7% | 20.1% | 21.5% | 21.3% | 21.7% | 19.3% | 18.4% | 14.9% |
| Net sales 1 | 6,319 | 6,848 | 6,833 | 6,510 | 6,948 | 7,355 | 7,813 | 8,339 |
| EBITDA 1 | 1,650 | 2,051 | 1,955 | 1,876 | 1,967 | 2,112 | 2,319 | 2,567 |
| EBIT 1 | 1,523 | 1,857 | 1,875 | 1,721 | 1,783 | 1,936 | 2,119 | 2,330 |
| Net income 1 | 1,210 | 1,254 | 1,240 | 1,289 | 1,303 | 1,496 | 1,639 | 1,842 |
| Net Debt 1 | 1,154 | 1,716 | 1,145 | 2,061 | 1,565 | 849.6 | -489.6 | -1,661 |
| Reference price 2 | 157.49 | 138.35 | 103.37 | 130.31 | 146.36 | 125.81 | 125.81 | 125.81 |
| Nbr of stocks (in thousands) | 302,723 | 296,041 | 292,587 | 287,328 | 283,500 | 282,840 | - | - |
| Announcement Date | 22/11/21 | 21/11/22 | 20/11/23 | 25/11/24 | 24/11/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 23.59x | 4.95x | 17.25x | 0.82% | 35.58B | ||
| 28.27x | 4.92x | 19.48x | 0.33% | 190B | ||
| 54.99x | 14.23x | 33.19x | -.--% | 173B | ||
| 40.78x | 6.67x | 21.64x | 0.59% | 150B | ||
| 36.66x | 5.96x | 19.44x | -.--% | 111B | ||
| 20.19x | 2.37x | 11.66x | 2.6% | 53.87B | ||
| 33.52x | 6.72x | 22.23x | -.--% | 44.03B | ||
| 23.86x | 6.33x | 16.25x | 0.96% | 36.79B | ||
| 16.86x | 1.88x | 10.19x | 0.2% | 36.61B | ||
| 23.46x | 5.98x | 16.99x | 2.82% | 32.52B | ||
| Average | 30.22x | 6.00x | 18.83x | 0.83% | 86.27B | |
| Weighted average by Cap. | 35.58x | 7.13x | 21.53x | 0.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- A Stock
- Valuation Agilent Technologies, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















